| 摘要 |
The present invention provides nucleic acid sequences, of an alternative splicing variant of metabotropic glutamate receptor (mGluR). The invention also provides amino acid sequences coded by the isolated nucleic sequences purified antibodies, which binds specifically to the amino acid sequences, and expression vectors comprising any one of the nucleic acid sequences. The invention also provides pharmaceutical compositions comprising as an active ingredient the expression vector or an amino acid sequence.
|
